DUBLIN--(BUSINESS WIRE)--
Dublin - Research and Markets (http://www.researchandmarkets.com/research/6jtw3v/global_malignant_m)
has announced the addition of the "Global
Malignant Melanoma Drug Pipeline Capsule - 2012" report to
their offering.
Fore Pharma's latest report Global Malignant Melanoma Drug Pipeline
Capsule - 2012' is an outline of all the key research and development
(R&D) activities of the global Malignant Melanoma drug market. It covers
information on key pipeline molecules in various stages of R&D including
all the phases of clinical trials, preclinical research, and drug
discovery. The report is up-to-date with full coverage of the licensing
activities and partnerships.
This report helps executives to keep a track of their competitors and
understand their pipeline molecules. The information presented in this
report can be used for identifying the partners, prioritizing,
evaluating opportunities, developing business development strategies,
and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and
mechanism of action across the different stages of R&D. It includes
registered / preregistered stage, phase 3 clinical trial, phase 2
clinical trial, phase 1 clinical trial, preclinical research, and drug
discovery. It also provides information on pipeline molecules developed
in leading geographies including the U.S., Canada, France, Germany,
U.K., Italy, and Spain by various stages of R&D. Licensing activities
and partnerships in the Malignant Melanoma drug market is thoroughly
covered by company and licensee with the deal summary.
Key Features of the Report:
- Malignant Melanoma: Overview
- Malignant Melanoma Drug Pipeline Overview
- Malignant Melanoma Phase 3 Clinical Trial Drug Pipeline Insights
- Malignant Melanoma Phase 2 Clinical Trial Drug Pipeline Insights
- Malignant Melanoma Phase 1 Clinical Trial Drug Pipeline Insights
- Malignant Melanoma Preclinical Research Drug Pipeline Insights
- Malignant Melanoma Drug Discovery Pipeline Insights
- Geographic Landscape of Malignant Melanoma R&D Activities
- Malignant Melanoma R&D Activities in North America
- Malignant Melanoma R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Malignant Melanoma
Drug Market
For more information visit http://www.researchandmarkets.com/research/6jtw3v/global_malignant_m
